Show simple item record

dc.contributor.authorBousfield, George R.en_US
dc.contributor.authorButnev, Viktor Y.en_US
dc.contributor.authorGotschall, R. Russellen_US
dc.contributor.authorBaker, Vanda L.en_US
dc.contributor.authorMoore, William T.en_US
dc.date.accessioned2012-01-24T17:49:59Z
dc.date.available2012-01-24T17:49:59Z
dc.date.issued1996-12-20en_US
dc.identifier9027339en_US
dc.identifierHD-29047en_US
dc.identifier7500844en_US
dc.identifier.citationMolecular and cellular endocrinology. 1996 Dec 20; 125(1-2): 3-19.en_US
dc.identifier.issn0303-7207en_US
dc.identifier.urihttp://dx.doi.org/10.1016/S0303-7207(96)03945-7
dc.identifier.urihttp://hdl.handle.net/10057/4209
dc.descriptionClick on the DOI link below to access the article (may not be free).en_US
dc.description.abstractThere are two species for which both pituitary and placental gonadotropins are readily available, humans and horses. The human gonadotropins are better characterized than equine gonadotropins. Nevertheless, the latter are very interesting because they provide exceptions to some of the general structure-function principles derived from studies on human and other mammalian gonadotropins. For example, separate genes encode the hLH beta and hCG beta subunits while a single gene encodes eLH beta and eCG beta. Thus, eCG and eLH differ only in their oligosaccharide moieties and eLH is the only LH that possesses the O-glycosylated C-terminal extension previously believed to be restricted to chorionic gonadotropins. Truncation experiments involving eLH beta and hCG beta have suggested the C-terminal extension has no effect on receptor binding. However, the largest of three eCG forms which differ only in the extent of O-glycosylation possessed reduced affinity for LH and FSH receptors. This result suggested that effects of O-glycosylation need to be considered when examining the glycosylation differences between eLH and eCG responsible for the 10-fold lower eCG receptor binding affinity compared with that of eLH. Contribution of alpha Asn56 N-linked oligosaccharides to the different biological activities of eLH and eCG has been evaluated following selective removal using peptide-N-glycanase digestion of native equine alpha-subunit preparations. Hormones-specific patterns of glycosylation were observed on alpha Asn56 of eLH, eFSH, and eCG. Removal of alpha Asn56 oligosaccharides increased the rate of subunit association, the extent of association, and receptor binding activity. Some unassociated alpha-subunit oligosaccharides were identified which may interfere with subunit association because they were more abundant in unassociated subunit oligosaccharide maps than in a total oligosaccharide map. This was most striking in the case of eCG alpha in which two minor peaks became the major oligosaccharide peaks detectable in the unassociated eCG alpha fraction following association with eLH beta and eFSH beta. The biological activities exhibited by hybrid hormones, eLH alpha reassociated with oLH beta and pLH beta, found to be greater than those of oLH and pLH provided an interesting exception to the general rule that the beta-subunit determines the potency of the heterodimer. LH receptor binding activities of eLH beta-chimeric ovine/equine alpha-subunits suggested that the equine alpha-subunit N-terminal domain may be responsible for this effect. Equine FSH has higher FSH receptor binding activity than human, ovine, and porcine FSH preparations. This probably results from two factors. First, the presence of the equine alpha-subunit promotes receptor binding as noted above. Second, the overall -2 charge of the eFSH beta determinant loop, which is less negative that the -3 observed in other species, results from the presence of an Asn residue at position 88 instead of Asp. This apparently facilitates binding to the FSH receptor.en_US
dc.description.sponsorshipNICHD NIH HHSen_US
dc.language.isoengen_US
dc.publisherElsevier Irelanden_US
dc.relation.ispartofseriesMolecular and cellular endocrinologyen_US
dc.sourceNLMen_US
dc.subjectComparative Studyen_US
dc.subjectResearch Support, U.S. Gov't, P.H.S.en_US
dc.subjectReviewen_US
dc.subject.meshAmino Acid Sequenceen_US
dc.subject.meshAnimalsen_US
dc.subject.meshChorionic Gonadotropin/chemistryen_US
dc.subject.meshFollicle Stimulating Hormone/chemistryen_US
dc.subject.meshGlycosylationen_US
dc.subject.meshGonadotropins/chemistryen_US
dc.subject.meshHorsesen_US
dc.subject.meshHumansen_US
dc.subject.meshLuteinizing Hormone/chemistryen_US
dc.subject.meshMolecular Sequence Dataen_US
dc.subject.meshRecombinant Fusion Proteinsen_US
dc.subject.meshLuteinizing Hormone/metabolismen_US
dc.subject.meshChorionic Gonadotropin/metabolismen_US
dc.subject.meshFollicle Stimulating Hormone/metabolismen_US
dc.titleStructural features of mammalian gonadotropinsen_US
dc.typeArticleen_US
dc.description.versionpeer revieweden_US
dc.rights.holderCopyright © 1996, Elsevieren_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record